Cornell researchers and parent educators are identifying how the opioid crisis has ravaged New York state families and the solutions that help parents and children reunify.
An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease.
In the second season of the Inside Medicine online video series, Weill Cornell Medicine chronicles three stories emblematic of the institution’s dedication to translational research.
Yi Wen, a fifth-year doctoral student in the field of biochemistry, molecular and cell biology, won the 2018 Harry and Samuel Mann Outstanding Graduate Student Award.
In an April 11 lecture, Stacey Langwick explored how concerns over toxicity shape public conversations about the forms of nourishment and modes of healing that make places livable.
The university beginning online classes for the remainder of the semester continues a long history of remote instruction. Liberty Hyde Bailey and Martha Van Rensselaer designed Cornell’s first correspondence courses in 1896 and 1900, respectively.
When Lou Walcer ’74 stepped into the new business incubator in Weill Hall 10 years ago, he saw opportunity. Now, the center has enjoyed a decade of success.
Kidney ultrasound plus a visual examination of the bladder and urethra appears to be the most cost-effective way to screen for cancers of the genitourinary tract of those with blood in their urine.
By learning how an immune cell called Tr1 works in the body, researchers hope to one day harness the cells to better treat allergies and infections, according to new Cornell research.
A simple blood test may better predict which patients diagnosed with liver cancer will experience disease reoccurrence, according to new research from Weill Cornell Medicine scientists.